Cat.#: ACPP-1684
| Despition | GNB3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 80.0% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1181 | Synthetic Nanodisc Human CX3CR1 Protein (AC1181) | 10 µg | inquiry |
| ACPP-1195 | CaMKII gamma Blocking Peptide (AC1195) | 250 µg | inquiry |
| ACPP-1513 | Human FGFR2 Protein (AC1513) | 2 µg | inquiry |
| ACPP-1345 | DISC1 Blocking Peptide (AC1345) | 250 µg | inquiry |
| ACPP-1286 | Bestrophin 2 Blocking Peptide (AC1286) | 250 µg | inquiry |
| ACPP-1290 | Insulin Receptor Blocking Peptide (AC1290) | 250 µg | inquiry |
| ACPP-1689 | Human DUSP26 Protein (AC1689) | 5 µg | inquiry |
| ACPP-1412 | Human SLC4A4 Protein (AC1412) | 5 µg | inquiry |
| ACPP-1314 | Syndecan-1 Blocking Peptide (AC1314) | 250 µg | inquiry |
| ACPP-1623 | Human USH1C Protein (AC1623) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.